369 related articles for article (PubMed ID: 32703421)
1. Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents.
Irham LM; Chou WH; Calkins MJ; Adikusuma W; Hsieh SL; Chang WC
Biochem Biophys Res Commun; 2020 Aug; 529(2):263-269. PubMed ID: 32703421
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
3.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Front Genet; 2021; 12():667231. PubMed ID: 33968142
[TBL] [Abstract][Full Text] [Related]
4. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
Zarubin A; Stepanov V; Markov A; Kolesnikov N; Marusin A; Khitrinskaya I; Swarovskaya M; Litvinov S; Ekomasova N; Dzhaubermezov M; Maksimova N; Sukhomyasova A; Shtygasheva O; Khusnutdinova E; Radzhabov M; Kharkov V
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375616
[TBL] [Abstract][Full Text] [Related]
5. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
7. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
[TBL] [Abstract][Full Text] [Related]
8. Assessment of risk conferred by coding and regulatory variations of
Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
J Genet; 2020; 99(1):. PubMed ID: 32661206
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2.
Tarek M; Abdelzaher H; Kobeissy F; El-Fawal HAN; Salama MM; Abdelnaser A
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356057
[TBL] [Abstract][Full Text] [Related]
10. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.
Piva F; Sabanovic B; Cecati M; Giulietti M
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):451-455. PubMed ID: 33245471
[TBL] [Abstract][Full Text] [Related]
11. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (
Kim YC; Jeong BH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396837
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of TMPRSS2 rs2070788 polymorphism with COVID-19 case fatality rate among Indian populations.
Pandey RK; Srivastava A; Singh PP; Chaubey G
Infect Genet Evol; 2022 Mar; 98():105206. PubMed ID: 34995811
[TBL] [Abstract][Full Text] [Related]
13. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
14. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
15. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
[TBL] [Abstract][Full Text] [Related]
16. Ocular Surface Expression of SARS-CoV-2 Receptors.
Leonardi A; Rosani U; Brun P
Ocul Immunol Inflamm; 2020 Jul; 28(5):735-738. PubMed ID: 32589459
[TBL] [Abstract][Full Text] [Related]
17. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Tayoun AA; Loney T; Uddin M; Senok A; Al Heialy S; Hamoudi R; Kashour T; Alsheikh-Ali A; Hamid Q; Halwani R
Clin Transl Sci; 2020 Nov; 13(6):1048-1054. PubMed ID: 32799423
[TBL] [Abstract][Full Text] [Related]
18. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
19. Gene of the month:
Thunders M; Delahunt B
J Clin Pathol; 2020 Dec; 73(12):773-776. PubMed ID: 32873700
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
Bestle D; Heindl MR; Limburg H; Van Lam van T; Pilgram O; Moulton H; Stein DA; Hardes K; Eickmann M; Dolnik O; Rohde C; Klenk HD; Garten W; Steinmetzer T; Böttcher-Friebertshäuser E
Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32703818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]